Published in Br J Nutr on January 19, 2010
Variation in base excision repair capacity. Mutat Res (2010) 1.19
Arsenic in cancer treatment: challenges for application of realgar nanoparticles (a minireview). Toxins (Basel) (2010) 1.04
Effects of micronutrients on DNA repair. Eur J Nutr (2012) 1.01
Comet assay to measure DNA repair: approach and applications. Front Genet (2014) 0.95
Genetics of oxidative stress in obesity. Int J Mol Sci (2014) 0.78
DNA damage and oxidative stress response to selenium yeast in the non-smoking individuals: a short-term supplementation trial with respect to GPX1 and SEPP1 polymorphism. Eur J Nutr (2015) 0.77
Can consumption of raw vegetables decrease the count of sister chromatid exchange? Results from a cross-sectional study in Krakow, Poland. Eur J Nutr (2014) 0.76
The association between deficient manganese levels and breast cancer: a meta-analysis. Int J Clin Exp Med (2015) 0.75
A randomized trial of genotype-guided dosing of warfarin. N Engl J Med (2013) 7.18
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet (2011) 6.77
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. Blood (2005) 4.91
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med (2008) 3.76
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology (2010) 2.95
Tracking of obesity-related behaviours from childhood to adulthood: A systematic review. Maturitas (2011) 2.59
Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nat Med (2012) 2.28
Assessing the survival of transgenic plant DNA in the human gastrointestinal tract. Nat Biotechnol (2004) 2.26
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology (2011) 2.01
Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury. J Hepatol (2010) 1.97
Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr (2007) 1.95
Selenium in human health and disease. Antioxid Redox Signal (2011) 1.86
Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients. Transplantation (2003) 1.83
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics. Clin Pharmacol Ther (2005) 1.74
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver. J Hepatol (2011) 1.73
Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol (2002) 1.73
A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res (Phila) (2011) 1.64
A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clin Sci (Lond) (2011) 1.59
Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J (2007) 1.58
CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6alpha-hydroxylase activity in human liver microsomes. Biochem Pharmacol (2002) 1.49
Degradation of transgenic DNA from genetically modified soya and maize in human intestinal simulations. Br J Nutr (2002) 1.48
Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res (2006) 1.48
CYP3A5 phenotype-genotype correlations in a British population. Br J Clin Pharmacol (2003) 1.47
Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma. Clin Cancer Res (2012) 1.46
APOE genotype makes a small contribution to warfarin dose requirements. Pharmacogenet Genomics (2006) 1.45
Longitudinal change in food habits between adolescence (11-12 years) and adulthood (32-33 years): the ASH30 Study. J Public Health (Oxf) (2006) 1.39
Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study. Mech Ageing Dev (2011) 1.36
Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology (2004) 1.35
Are behavioral interventions effective in increasing physical activity at 12 to 36 months in adults aged 55 to 70 years? A systematic review and meta-analysis. BMC Med (2013) 1.32
Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin. Clin Pharmacol Ther (2004) 1.31
Quantification of mitochondrial DNA mutation load. Aging Cell (2009) 1.29
The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors. Br J Clin Pharmacol (2012) 1.28
Splice variants of the human zinc transporter ZnT5 (SLC30A5) are differentially localized and regulated by zinc through transcription and mRNA stability. J Biol Chem (2007) 1.26
Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex. Am J Clin Nutr (2008) 1.26
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design. Pharmacogenomics (2009) 1.25
Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Res Clin Pract (2005) 1.24
Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology (2002) 1.23
Do we know enough? A scientific and ethical analysis of the basis for genetic-based personalized nutrition. Genes Nutr (2013) 1.23
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children. Blood (2011) 1.22
Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. Pharmacogenet Genomics (2012) 1.21
A novel zinc-regulated human zinc transporter, hZTL1, is localized to the enterocyte apical membrane. J Biol Chem (2002) 1.21
Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide. Clin Pharmacol Ther (2003) 1.21
Global LINE-1 DNA methylation is associated with blood glycaemic and lipid profiles. Int J Epidemiol (2012) 1.20
Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis. J Nutr (2013) 1.19
Challenges of molecular nutrition research 6: the nutritional phenotype database to store, share and evaluate nutritional systems biology studies. Genes Nutr (2010) 1.18
Towards measurement of the Healthy Ageing Phenotype in lifestyle-based intervention studies. Maturitas (2013) 1.17
Design and baseline characteristics of the Food4Me study: a web-based randomised controlled trial of personalised nutrition in seven European countries. Genes Nutr (2014) 1.17
Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT. PLoS One (2013) 1.16
Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK. BMC Public Health (2009) 1.16
Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status. Antioxid Redox Signal (2009) 1.15
Online dietary intake estimation: the Food4Me food frequency questionnaire. J Med Internet Res (2014) 1.14
Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism. Pharmacogenetics (2004) 1.14
Comparison of methods for quantification of global DNA methylation in human cells and tissues. PLoS One (2013) 1.14
Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr (2008) 1.13
Genetic and non-genetic influences during pregnancy on infant global and site specific DNA methylation: role for folate gene variants and vitamin B12. PLoS One (2012) 1.12
Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.12
Bioethical considerations for human nutrigenomics. Annu Rev Nutr (2008) 1.11
ZnT5 variant B is a bidirectional zinc transporter and mediates zinc uptake in human intestinal Caco-2 cells. J Biol Chem (2007) 1.10
Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury. Hepatology (2013) 1.10
Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study. Pharmacogenet Genomics (2009) 1.09
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. J Hepatol (2011) 1.09
Online dietary intake estimation: reproducibility and validity of the Food4Me food frequency questionnaire against a 4-day weighed food record. J Med Internet Res (2014) 1.09
Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics. Pharmacogenomics (2011) 1.09
Blood as a surrogate marker for tissue-specific DNA methylation and changes due to folate depletion in post-partum female mice. Mol Nutr Food Res (2011) 1.09
A novel single nucleotide polymorphism in the 3' untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol Dis (2002) 1.09
Genetics of alcoholic and nonalcoholic fatty liver disease. Semin Liver Dis (2011) 1.08
Supplementation of healthy volunteers with nutritionally relevant amounts of selenium increases the expression of lymphocyte protein biosynthesis genes. Am J Clin Nutr (2008) 1.08
Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis (2010) 1.07
Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways. Ann Rheum Dis (2010) 1.06
The Micronutrient Genomics Project: a community-driven knowledge base for micronutrient research. Genes Nutr (2010) 1.06
Conserved MIP receptor-ligand pair regulates Platynereis larval settlement. Proc Natl Acad Sci U S A (2013) 1.05
Nutritional factors and gender influence age-related DNA methylation in the human rectal mucosa. Aging Cell (2012) 1.04
Accuracy of estimates of food portion size using food photographs--the importance of using age-appropriate tools. Public Health Nutr (2006) 1.04
Proline betaine and its biotransformation products in fasting urine samples are potential biomarkers of habitual citrus fruit consumption. Br J Nutr (2011) 1.02
Comparison of mitochondrial mutation spectra in ageing human colonic epithelium and disease: absence of evidence for purifying selection in somatic mitochondrial DNA point mutations. PLoS Genet (2012) 1.01
Responses of biomarkers of folate and riboflavin status to folate and riboflavin supplementation in healthy and colorectal polyp patients (the FAB2 Study). Cancer Epidemiol Biomarkers Prev (2007) 1.01
Changing foodscapes 1980-2000, using the ASH30 Study. Appetite (2009) 1.01
Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch Toxicol (2002) 1.00
Low-carbohydrate diet versus caloric restriction: effects on weight loss, hormones, and colon tumor growth in obese mice. Nutr Cancer (2008) 0.99
Annexin A2 binds to the localization signal in the 3' untranslated region of c-myc mRNA. FEBS J (2005) 0.99
The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fish oil fatty acids intakes. Annu Rev Nutr (2011) 0.97
Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon. Br J Clin Pharmacol (2014) 0.97
Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms. Proc Nutr Soc (2003) 0.96
Raised adolescent body mass index predicts the development of adiposity and a central distribution of body fat in adulthood: a longitudinal study. Obes Facts (2009) 0.96
Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation. PLoS One (2013) 0.95
Inhibition of methylation decreases osteoblast differentiation via a non-DNA-dependent methylation mechanism. Bone (2009) 0.94
Postnatal growth and DNA methylation are associated with differential gene expression of the TACSTD2 gene and childhood fat mass. Diabetes (2011) 0.94
Starch digestion, large-bowel fermentation and intestinal mucosal cell proliferation in rats treated with the alpha-glucosidase inhibitor acarbose. Br J Nutr (2004) 0.94
Relevance of nonsynonymous CYP2C8 polymorphisms to 13-cis retinoic acid and paclitaxel hydroxylation. Drug Metab Dispos (2010) 0.94
Effectiveness of dietary interventions among adults of retirement age: a systematic review and meta-analysis of randomized controlled trials. BMC Med (2014) 0.94
Defects in multiple complexes of the respiratory chain are present in ageing human colonic crypts. Exp Gerontol (2010) 0.94
Supporting well-being in retirement through meaningful social roles: systematic review of intervention studies. Milbank Q (2013) 0.93